Clinical Trial: Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas

Brief Summary: This open-label, randomized, parallel-group clinical study is designed to compare the efficacy and safety of the topical antibiotic, sisomicin cream, with that of another topical antibiotic cream, nadifloxacin cream, in the treatment of Indian patients with primary pyodermas.

Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Merck Sharp & Dohme Corp.

Dates:
Date Received: September 16, 2005
Date Started: May 2007
Date Completion:
Last Updated: June 2, 2015
Last Verified: June 2015